---
schema_version: "secwatch.filing_event.v1"
accession: "0001079973-23-000460"
form_type: "8-K"
ticker: null
cik: "0001602078"
company_name: "Nemaura Medical Inc."
filed_at: "2023-04-07T23:59:59+00:00"
generated_at: "2026-06-17T04:36:21.510889+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Nemaura Medical receives Nasdaq deficiency notices for MVLS and bid price; 180-day cure periods

## Summary
- On April 3, 2023, Nasdaq notified Nemaura of noncompliance with $35M minimum market value of listed securities rule.
- On April 7, 2023, Nasdaq notified Nemaura of noncompliance with $1.00 minimum bid price requirement.
- Company has 180 calendar days (until October 2/3, 2023) to regain compliance on each deficiency.
- Deficiencies have no immediate effect on listing or trading of NMRD common stock on Nasdaq.
- Company is evaluating alternatives but no decisions made; compliance not assured.

## SEC filing metadata
- accession: 0001079973-23-000460
- form_type: 8-K
- cik: 0001602078
- company_name: Nemaura Medical Inc.
- filed_at: 2023-04-07T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1602078/000107997323000460/0001079973-23-000460-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1602078/000107997323000460/nmra_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001079973-23-000460
- JSON: https://secwatch.observer/filing/0001079973-23-000460.json
- Plain text: https://secwatch.observer/filing/0001079973-23-000460.txt

## Key facts
- Listing & Compliance Notices
  Nemaura Medical Inc. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: noncompliance notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: April 7, 2023, the Company received written notice (the “Bid Price Notice”) from the Nasdaq Staff indicating that the Company is not in compliance with the $1.00 Minimum Bid Price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market. The notification of noncompliance has no immediate effect on the listing or trading of the Company’s common stock on the Nasdaq Capital Market under the symbol “NMRD,” and the Company is currently monitoring the closing bid price of its common stock and evaluating its alternatives, if appropriate, to resolve th
  evidence_url: https://www.sec.gov/Archives/edgar/data/1602078/000107997323000460/0001079973-23-000460-index.htm
- Listing & Compliance Notices
  Nemaura Medical Inc. received a nasdaq noncompliance notice notice regarding market value (rules 5550(b)(2)).
  - Exchange: nasdaq
  - Notice: noncompliance notice
  - Deficiency: market value
  - Rules: 5550(b)(2)
  source text: April 3, 2023, Nemaura Medical Inc. (the “Company”) received a written notice (the “MVLS Notice”) from the Nasdaq Listing Qualification Department (the “Nasdaq Staff”) indicating that the Company is not in compliance with the $35 million minimum market value of listed securities requirement set forth in Nasdaq Listing Rule 5550(b)(2) for continued listing on the Nasdaq Capital Market. The notification of noncompliance has no immediate effect on the listing or trading of the Company’s common stock on the Nasdaq Capital Market under the symbol “NMRD,” and the Company is currently monitoring the
  evidence_url: https://www.sec.gov/Archives/edgar/data/1602078/000107997323000460/0001079973-23-000460-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.